Moreover, in a transgenic mouse model of AD, the same authors previously demonstrated that CR antagonizes Aβ neuropathology by increasing the SIRT1 and NAD+/nicotinamide ratio (Qin et al., 2006b). This evidence concerns the gene SIRT1 and Alzheimer disease.